UFP Technologies, Inc. (UFPT)
305.39
-3.74
(-1.21%)
USD |
NASDAQ |
Aug 24, 16:00
306.10
+0.71
(+0.23%)
Pre-Market: 08:47
UFP Technologies Enterprise Value : 2.493B for Aug. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 2.493B |
| August 21, 2026 | 2.522B |
| August 20, 2026 | 2.484B |
| August 19, 2026 | 2.550B |
| August 18, 2026 | 2.559B |
| August 17, 2026 | 2.616B |
| August 14, 2026 | 2.620B |
| August 13, 2026 | 2.605B |
| August 12, 2026 | 2.625B |
| August 11, 2026 | 2.621B |
| August 10, 2026 | 2.645B |
| August 07, 2026 | 2.560B |
| August 06, 2026 | 2.543B |
| August 05, 2026 | 2.622B |
| August 04, 2026 | 2.721B |
| August 03, 2026 | 2.200B |
| July 31, 2026 | 2.101B |
| July 30, 2026 | 2.103B |
| July 29, 2026 | 2.103B |
| July 28, 2026 | 2.126B |
| July 27, 2026 | 2.053B |
| July 24, 2026 | 1.965B |
| July 23, 2026 | 1.957B |
| July 22, 2026 | 1.970B |
| July 21, 2026 | 2.017B |
| Date | Value |
|---|---|
| July 20, 2026 | 2.030B |
| July 17, 2026 | 2.002B |
| July 16, 2026 | 2.116B |
| July 15, 2026 | 2.032B |
| July 14, 2026 | 1.910B |
| July 13, 2026 | 1.965B |
| July 10, 2026 | 1.962B |
| July 09, 2026 | 2.061B |
| July 08, 2026 | 2.076B |
| July 07, 2026 | 2.173B |
| July 06, 2026 | 2.235B |
| July 02, 2026 | 2.237B |
| July 01, 2026 | 2.208B |
| June 30, 2026 | 2.181B |
| June 29, 2026 | 2.176B |
| June 26, 2026 | 2.146B |
| June 25, 2026 | 2.091B |
| June 24, 2026 | 2.016B |
| June 23, 2026 | 1.950B |
| June 22, 2026 | 1.941B |
| June 18, 2026 | 1.987B |
| June 17, 2026 | 1.898B |
| June 16, 2026 | 1.933B |
| June 15, 2026 | 1.944B |
| June 12, 2026 | 1.954B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 229.54B |
| AngioDynamics, Inc. | 614.71M |
| Alphatec Holdings, Inc. | 1.920B |
| AtriCure, Inc. | 2.413B |
| Baxter International, Inc. | 20.38B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 20.85M |
| Revenue (Quarterly) | 173.96M |
| Total Expenses (Quarterly) | 153.11M |
| EPS Diluted (Quarterly) | 2.677 |
| Gross Profit Margin (Quarterly) | 29.27% |
| Profit Margin (Quarterly) | 11.99% |
| Earnings Yield | 3.04% |
| Operating Earnings Yield | 4.04% |
| Normalized Earnings Yield | 3.032 |